Prevalence of titin truncating variants in general population

PLoS ONE

Volumn 10, Issue 12, 2015, Pages

  Akinrinade, Oyediran ^a   Koskenvuo, Juha W ^b,c   Alastalo, Tero Pekka ^a,b  

^a UNIVERSITY OF HELSINKI AND HELSINKI UNIVERSITY HOSPITAL   (Finland)

^b Blueprint Genetics   (Finland)

^c HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

CONNECTIN; MESSENGER RNA; TTN PROTEIN, HUMAN;

ARTICLE; BIOINFORMATICS; CONTROLLED STUDY; CPG ISLAND; DNA LIBRARY; FRAMESHIFT MUTATION; GENETIC ANALYSIS; GENETIC VARIABILITY; HUMAN; NONSENSE MUTATION; PREVALENCE; SINGLE NUCLEOTIDE POLYMORPHISM; TTN GENE; CHEMISTRY; CONGESTIVE CARDIOMYOPATHY; DNA MUTATIONAL ANALYSIS; DNA SEQUENCE; GENETIC DATABASE; GENETIC VARIATION; GENETICS;

CARDIOMYOPATHY, DILATED; CONNECTIN; DATABASES, GENETIC; DNA MUTATIONAL ANALYSIS; GENETIC VARIATION; HUMANS; POLYMORPHISM, SINGLE NUCLEOTIDE; PREVALENCE; SEQUENCE ANALYSIS, DNA;

EID: 84956904418     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0145284     Document Type: Article

References (37)

1. Itoh-Satoh M, Hayashi T, Nishi H, Koga Y, Arimura T, Koyanagi T, et al. Titin mutations as the molecular basis for dilated cardiomyopathy. Biochemical and biophysical research communications. 2002; 291 (2):385-93. doi:10.1006/bbrc.2002.6448 PMID: 11846417.
2. Gerull B, Atherton J, Geupel A, Sasse-Klaassen S, Heuser A, Frenneaux M, et al. Identification of a novel frameshift mutation in the giant muscle filament titin in a large Australian family with dilated cardiomyopathy. Journal of molecular medicine. 2006; 84(6):478-83. doi:10.1007/s00109-006-0060-6 PMID: 16733766.
3. Matsumoto Y, Hayashi T, Inagaki N, Takahashi M, Hiroi S, Nakamura T, et al. Functional analysis of titin/connectin N2-B mutations found in cardiomyopathy. Journal of muscle research and cell motility. 2005; 26(6-8):367-74. doi:10.1007/s10974-005-9018-5 PMID: 16465475.
4. Satoh M, Takahashi M, Sakamoto T, Hiroe M, Marumo F, Kimura A. Structural analysis of the titin gene in hypertrophic cardiomyopathy: identification of a novel disease gene. Biochemical and biophysical research communications. 1999; 262(2):411-7. doi:10.1006/bbrc.1999.1221 PMID: 10462489.
5. Taylor M, Graw S, Sinagra G, Barnes C, Slavov D, Brun F, et al. Genetic variation in titin in arrhythmogenic right ventricular cardiomyopathy-overlap syndromes. Circulation. 2011; 124(8):876-85doi:10.1161/CIRCULATIONAHA.110.005405 PMID: 21810661; PubMed Central PMCID: PMC3167235.
6. Carmignac V, Salih MA, Quijano-Roy S, Marchand S, Al Rayess MM, Mukhtar MM, et al. C-terminal titin deletions cause a novel early-onset myopathy with fatal cardiomyopathy. Annals of neurology. 2007; 61(4):340-51. doi:10.1002/ana.21089 PMID: 17444505.
7. Yoskovitz G, Peled Y, Gramlich M, Lahat H, Resnik-Wolf H, Feinberg MS, et al. A novel titin mutation in adult-onset familial dilated cardiomyopathy. The American journal of cardiology. 2012; 109(11):1644- 50. doi:10.1016/j.amjcard.2012.01.392 PMID: 22475360.
8. Gerull B, Gramlich M, Atherton J, McNabb M, Trombitas K, Sasse-Klaassen S, et al. Mutations of TTN, encoding the giant muscle filament titin, cause familial dilated cardiomyopathy. Nature genetics. 2002; 30(2):201-4. doi:10.1038/ng815 PMID: 11788824.
9. Herman DS, Lam L, Taylor MR, Wang L, Teekakirikul P, Christodoulou D, et al. Truncations of titin causing dilated cardiomyopathy. The New England journal of medicine. 2012; 366(7):619-28doi:10.1056/NEJMoa1110186 PMID: 22335739; PubMed Central PMCID: PMC3660031.
10. Roberts AM, Ware JS, Herman DS, Schafer S, Baksi J, Bick AG, et al. Integrated allelic, transcriptional, and phenomic dissection of the cardiac effects of titin truncations in health and disease. Science translational medicine. 2015; 7(270):270ra6. doi:10.1126/scitranslmed.3010134 PMID: 25589632.
11. Akinrinade O, Ollila L, Vattulainen S, Tallila J, Gentile M, Salmenperä P, et al. Genetics and Genotype- Phenotype Correlations in Finnish Patients with Dilated Cardiomyopathy European heart journal. 2015. doi: In press.
12. van Spaendonck-Zwarts KY, Posafalvi A, van den Berg MP, Hilfiker-Kleiner D, Bollen IA, Sliwa K, et al. Titin gene mutations are common in families with both peripartum cardiomyopathy and dilated cardiomyopathy. European heart journal. 2014; 35(32):2165-73. doi:10.1093/eurheartj/ehu050 PMID: 24558114.
13. Pugh TJ, Kelly MA, Gowrisankar S, Hynes E, Seidman MA, Baxter SM, et al. The landscape of genetic variation in dilated cardiomyopathy as surveyed by clinical DNA sequencing. Genetics in medicine: official journal of the American College of Medical Genetics. 2014; 16(8):601-8. doi:10.1038/gim.2013.204 PMID: 24503780.
14. Haas J, Frese KS, Peil B, Kloos W, Keller A, Nietsch R, et al. Atlas of the clinical genetics of human dilated cardiomyopathy. European heart journal. 2014. doi:10.1093/eurheartj/ehu301PMID: 25163546.
15. Patricia Arscott M. Truncating Mutations in Titin Associated with Left Ventricular Noncompaction in Two Unrelated Families. Heart Rhythm 2014; May 9, 20142014.
16. Genomes Project C, Abecasis GR, Altshuler D, Auton A, Brooks LD, Durbin RM, et al. A map of human genome variation from population-scale sequencing. Nature. 2010; 467(7319):1061-73. doi:10.1038/nature09534PMID: 20981092; PubMed Central PMCID: PMC3042601.
17. NHLBI. Exome Variant Server, NHLBI Exome Sequencing Project (ESP), Seattle, WA. Available: http://evs.gs.washington.edu/EVS/. Accessed 15 January 2015.
18. Golbus JR, Puckelwartz MJ, Fahrenbach JP, Dellefave-Castillo LM, Wolfgeher D, McNally EM. Population- based variation in cardiomyopathy genes. Circulation Cardiovascular genetics. 2012; 5(4):391-9. doi:10.1161/CIRCGENETICS.112.962928 PMID: 22763267; PubMed Central PMCID: PMC3495587.
19. ExAC. Exome Aggregation Consortium (ExAC), Cambridge, MA. Available: http://exac.broadinstitute.org. Accessed 15 January 2015.
20. Bamford S, Dawson E, Forbes S, Clements J, Pettett R, Dogan A, et al. The COSMIC (Catalogue of Somatic Mutations in Cancer) database and website. British journal of cancer. 2004; 91(2):355-8. doi:10.1038/sj.bjc.6601894PMID: 15188009; PubMed Central PMCID: PMC2409828.
21. Pan S, Caleshu CA, Dunn KE, Foti MJ, Moran MK, Soyinka O, et al. Cardiac structural and sarcomere genes associated with cardiomyopathy exhibit marked intolerance of genetic variation. Circulation Cardiovascular genetics. 2012; 5(6):602-10. doi:10.1161/CIRCGENETICS.112.963421 PMID: 23074333; PubMed Central PMCID: PMC3526690.
22. Genomes Project C, Abecasis GR, Auton A, Brooks LD, DePristo MA, Durbin RM, et al. An integrated map of genetic variation from 1, 092 human genomes. Nature. 2012; 491(7422):56-65. doi:10.1038/nature11632 PMID: 23128226; PubMed Central PMCID: PMC3498066.
23. Rideout WM 3rd, Coetzee GA, Olumi AF, Jones PA. 5-Methylcytosine as an endogenous mutagen in the human LDL receptor and p53 genes. Science. 1990; 249(4974):1288-90. PMID: 1697983.
24. Krawczak M, Cooper DN. Single base-pair substitutions in pathology and evolution: Two sides to the same coin. Hum Mutat. 1996; 8(1):23-31. doi:10.1002/(SICI)1098-1004(1996)8:1<23::AIDHUMU3>3.0.CO;2-Q PMID: 8807332.
25. Cooper DN, Mort M, Stenson PD, Ball EV, Chuzhanova NA. Methylation-mediated deamination of 5- methylcytosine appears to give rise to mutations causing human inherited disease in CpNpG trinucleotides, as well as in CpG dinucleotides. Human genomics. 2010; 4(6):406-10. PMID: 20846930; PubMed Central PMCID: PMC3525222.
26. Movassagh M, Choy MK, Knowles DA, Cordeddu L, Haider S, Down T, et al. Distinct epigenomic features in end-stage failing human hearts. Circulation. 2011; 124(22):2411-22. doi:10.1161/CIRCULATIONAHA.111.040071PMID: 22025602; PubMed Central PMCID: PMC3634158.
27. Haas J, Frese KS, Park YJ, Keller A, Vogel B, Lindroth AM, et al. Alterations in cardiac DNA methylation in human dilated cardiomyopathy. EMBO molecular medicine. 2013; 5(3):413-29. doi:10.1002/emmm.201201553 PMID: 23341106; PubMed Central PMCID: PMC3598081.
28. Meurs KM, Kuan M. Differential methylation of CpG sites in two isoforms of myosin binding protein C, an important hypertrophic cardiomyopathy gene. Environmental and molecular mutagenesis. 2011; 52 (2):161-4. doi:10.1002/em.20596 PMID: 20740642.
29. Ceyhan-Birsoy O, Agrawal PB, Hidalgo C, Schmitz-Abe K, DeChene ET, Swanson LC, et al. Recessive truncating titin gene, TTN, mutations presenting as centronuclear myopathy. Neurology. 2013; 81 (14):1205-14. doi:10.1212/WNL.0b013e3182a6ca62PMID: 23975875; PubMed Central PMCID: PMC3795603.
30. Hackman P, Vihola A, Haravuori H, Marchand S, Sarparanta J, De Seze J, et al. Tibial muscular dystrophy is a titinopathy caused by mutations in TTN, the gene encoding the giant skeletal-muscle protein titin. American journal of human genetics. 2002; 71(3):492-500. doi:10.1086/342380 PMID: 12145747; PubMed Central PMCID: PMC379188.
31. Udd B, Vihola A, Sarparanta J, Richard I, Hackman P. Titinopathies and extension of the M-line mutation phenotype beyond distal myopathy and LGMD2J. Neurology. 2005; 64(4):636-42. doi:10.1212/01.WNL.0000151853.50144.82 PMID: 15728284.
32. Hackman P, Marchand S, Sarparanta J, Vihola A, Penisson-Besnier I, Eymard B, et al. Truncating mutations in C-terminal titin may cause more severe tibial muscular dystrophy (TMD). Neuromuscular disorders: NMD. 2008; 18(12):922-8. doi:10.1016/j.nmd.2008.07.010PMID: 18948003.
33. Chauveau C, Bonnemann CG, Julien C, Kho AL, Marks H, Talim B, et al. Recessive TTN truncating mutations define novel forms of core myopathy with heart disease. Human molecular genetics. 2014; 23(4):980-91. doi:10.1093/hmg/ddt494PMID: 24105469; PubMed Central PMCID: PMC3954110.
34. Evila A, Vihola A, Sarparanta J, Raheem O, Palmio J, Sandell S, et al. Atypical phenotypes in titinopathies explained by second titin mutations. Annals of neurology. 2014; 75(2):230-40. doi:10.1002/ana.24102 PMID: 24395473.
35. Dewey FE, Grove ME, Pan C, Goldstein BA, Bernstein JA, Chaib H, et al. Clinical interpretation and implications of whole-genome sequencing. Jama. 2014; 311(10):1035-45. doi:10.1001/jama.2014.1717PMID:24618965; PubMed Central PMCID: PMC4119063.
36. O'Rawe J, Jiang T, Sun G, Wu Y, Wang W, Hu J, et al. Low concordance of multiple variant-calling pipelines: practical implications for exome and genome sequencing. Genome medicine. 2013; 5(3):28. doi:10.1186/gm432PMID: 23537139; PubMed Central PMCID: PMC3706896.
37. Strom SP, Lee H, Das K, Vilain E, Nelson SF, Grody WW, et al. Assessing the necessity of confirmatory testing for exome-sequencing results in a clinical molecular diagnostic laboratory. Genetics in medicine: official journal of the American College of Medical Genetics. 2014; 16(7):510-5. doi:10.1038/gim.2013.183 PMID: 24406459; PubMed Central PMCID: PMC4079763. Titin Truncation Is a Rare Event in General Population PLOS.